Ivabradine: New Drug For The Heart Patients Approved


Ivabradine: New Drug For The Heart Patients Approved

A new study carried out by a team of doctors has proved that Ivabradine drug can help reduce the deaths caused by heart failure to a great extent. It is estimated that heart failure affects 900,000 people in UK, causing 100,000 deaths a year. However, the results of this drug are estimated to decline the death rate by more than a third.

Professor Martin Cowie, Consultant Cardiologist at the Royal Brompton Hospital in London who led this study, carried out a clinical trial ‘Shift’ before effusing the life saving statements. The clinical trials carried out on the drug showed that it abates the possibilities of death from heart failure by 39% and thus cutting the rate of hospital admissions by 24%.

A case that was considered while clinical trials added to the success story of this drug. Anne Tanner, who was diagnosed with heart failure in 2007, was put on this drug as part of her medication. The treatment has changed her life completely. She states that she is able to perform all the activities that she was unable to carry out before the treatment.

The main causes that doctors analyze in case of heart failure are articulated to be heart attack, that weaken the heart and due to this the pumping system is also damaged. As a result, there is a less supply of blood and thus oxygen to the heart. This drug further, acts by slowing down the heart beat. This action in turn helps the heart to pump oxygenated blood more efficiently. This drug is already used to treat angina.

The European Medicine Regulator, after beholding the consequences of the drug has approved its use for patients dealing with heart failure. This drug will be launched at a price rate that will cost no more than £1.50 a day, thus costing less than £10 a week.

Latest News

U.S. Crude Drops Further Due to Surplus Supply
CVC and CPPIB Outbid Others for a Possible Deal to Buy Petco for $4.7 Billion
US Government All Set to Introduce a New Law for Americans “Seriously Delinquent
Reportedly Pfizer Plans to Acquire Allergan in a Deal of $150 Billion or More
In October Most States Experienced a Drop in Unemployment Rate
San Francisco Fed President John Williams sees a “Strong Case” for an Interest
Cincinnati Shoppers have More Choice of Local Black Friday Deals this Year
Sliding Crude Prices Continue Giving the U.S Oil Producers Reasons to Cut Costs
American Airlines Revamps its Much Anticipated Loyalty Reward Program
Report says, Many Retailers Recycling Black Friday Deals
Optimistic Sales Posted by Retailers Walmart, Home Depot and TJX Spark a Positiv
Interest Rate Hike a Possibility or Not in December, is Still a matter